Hee J. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications
Advancing in vitro gut fermentation: the convergence of gut-on-a-chip and digital twins.
Journal: Current opinion in biotechnology
Published: March 16, 2026
Enhancing Translation of H&E to IHC with Robust Tumor-Infiltrating Lymphocytes Quantification Using Deep Generative Models: A Feasibility Study.
Journal: Journal of imaging informatics in medicine
Published: January 28, 2026
Spatial Interactions of CD103+ Tissue-Resident Memory T Cells in the Tumor Periphery Are Associated with Clinical Outcomes in Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy.
Journal: Cancer research and treatment
Published: December 29, 2025
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer.
Journal: Journal of breast cancer
Published: October 13, 2025
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy.
Journal: Korean journal of radiology
Published: September 23, 2025
Serial analysis of ESR1 mutations in cell-free DNA from hormone receptor-positive, HER2-negative metastatic breast cancer during palliative endocrine therapy.
Journal: Frontiers in oncology
Published: September 20, 2025
Prevalence of HER2-ultralow breast cancer in South Korea: a multicenter study by reassessment of HER2-zero cases.
Journal: Journal of pathology and translational medicine
Published: September 17, 2025
Long-Term Prognostic Value and Analytical Parameters of the Next-Generation Sequencing-Based Multigene Assay in Hormone Receptor-Positive, HER2-Negative Breast Cancer.
Journal: Cancer research and treatment
Published: July 07, 2025
SOD2 expression in patients with triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and prognosis.
Journal: Breast cancer research and treatment
Published: June 04, 2025
Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy.
Journal: Clinical breast cancer
Published: May 22, 2025
Characterization of undifferentiated carcinoma of the salivary gland: clinicopathological and immunohistochemical analyses in comparison with lymphoepithelial carcinoma.
Journal: Journal of pathology and translational medicine
Published: May 03, 2025
Last Updated: 09/26/2026